LifeVantage (LFVN) 10-Q 6 Feb 14 2014 Q2 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	6 Months Ended
	Dec. 31, 2013	Feb. 03, 2014
Document and Entity Information [Abstract]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	31-Dec-13	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q2	'
Trading Symbol	'LFVN	'
Entity Registrant Name	'LIFEVANTAGE CORPORATION	'
Entity Central Index Key	'0000849146	'
Current Fiscal Year End Date	'--06-30	'
Entity Filer Category	'Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	103,941,731

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (Unaudited) (USD $)	Dec. 31, 2013	Jun. 30, 2013
In Thousands, unless otherwise specified
Current assets	'	'
Cash and cash equivalents	$34,454	$26,299
Accounts receivable	873	1,789
Income tax receivable	651	2,150
Inventory	9,843	10,524
Current deferred income tax asset	2,885	2,885
Prepaid expenses and deposits	4,161	2,294
Total current assets	52,867	45,941
Long-term assets	'	'
Property and equipment, net	5,279	5,692
Intangible assets, net	1,731	1,747
Deferred debt offering costs, net	1,472	0
Long-term deferred income tax asset	730	730
Other long-term assets	1,315	1,374
TOTAL ASSETS	63,394	55,484
Current liabilities	'	'
Accounts payable	2,805	5,171
Commissions payable	7,183	7,564
Other accrued expenses	7,230	7,831
Short-term portion of debt	4,700	0
Total current liabilities	21,918	20,566
Long-term liabilities	'	'
Principal amount	42,300	0
Less: unamortized discount	-1,145	0
Long-term debt, net of unamortized discount	41,155	0
Other long-term liabilities	869	973
Total liabilities	63,942	21,539
Commitments and contingencies	'	'
Stockholders’ equity (deficit)	'	'
Preferred stock — par value $0.001 per share, 50,000 shares authorized, no shares issued or outstanding	0	0
Common stock — par value $0.001 per share, 250,000 shares authorized and 103,898 and 117,088 issued and outstanding as of December 31, 2013 and June 30, 2013, respectively	104	121
Additional paid-in capital	113,014	110,413
Accumulated deficit	-113,087	-76,476
Accumulated other comprehensive loss	-579	-113
Total stockholders’ equity (deficit)	-548	33,945
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)	$63,394	$55,484

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) (USD $)	Dec. 31, 2013	Jun. 30, 2013
Statement of Financial Position [Abstract]	'	'
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares authorized (in shares)	50,000,000	50,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares authorized (in shares)	250,000,000	250,000,000
Common stock, shares issued (in shares)	103,898,000	117,088,000
Common stock, shares outstanding (in shares)	103,898,000	117,088,000

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations and Other Comprehensive Income (Unaudited) (USD $)	3 Months Ended		6 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Income Statement [Abstract]	'	'	'	'
Sales, net	$51,538	$53,438	$102,866	$106,297
Cost of sales	7,944	8,799	15,753	16,606
Product recall costs	0	5,879	0	5,879
Gross profit	43,594	38,760	87,113	83,812
Operating expenses:	'	'	'	'
Sales and marketing	29,785	29,593	60,027	59,133
General and administrative	7,561	7,495	14,962	15,404
Research and development	584	742	891	1,257
Depreciation and amortization	498	443	997	681
Total operating expenses	38,428	38,273	76,877	76,475
Operating income	5,166	487	10,236	7,337
Other income (expense), net:	'	'	'	'
Interest and other income (expense), net	-365	-16	-327	-1
Total other income (expense)	-365	-16	-327	-1
Net income before income taxes	4,801	471	9,909	7,336
Income tax expense	-1,519	-262	-3,371	-2,963
Net income	3,282	209	6,538	4,373
Net income per share:	'	'	'	'
Basic	$0.03	$0	$0.06	$0.04
Diluted	$0.03	$0	$0.06	$0.03
Weighted average shares outstanding:	'	'	'	'
Basic	105,770	113,449	110,218	112,158
Diluted	112,392	127,131	117,363	126,046
Other comprehensive income, net of tax:	'	'	'	'
Foreign currency translation adjustment	-192	68	-466	63
Other comprehensive income, net of tax:	-192	68	-466	63
Comprehensive income	$3,090	$277	$6,072	$4,436

Condensed_Consolidated_Stateme1

Condensed Consolidated Statement of Stockholders' Equity (Deficit) (Unaudited) (USD $)	Total	Common stock	Additional paid-in capital	Accumulated deficit	Accumulated other comprehensive loss
In Thousands, unless otherwise specified
Beginning Balance at Jun. 30, 2013	$33,945	$121	$110,413	($76,476)	($113)
Beginning Balance (in shares) at Jun. 30, 2013	'	117,088	'	'	'
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'	'	'	'	'
Stock-based compensation	1,453	'	1,453	'	'
Exercise of options and warrants (in shares)	'	4,277	'	'	'
Exercise of options and warrants	1,152	4	1,148	'	'
Issuance of shares related to restricted stock (in shares)	'	125	'	'	'
Issuance of shares related to restricted stock	'	0	'	'	'
Shares canceled or surrendered as payment of tax withholding (in shares)	'	-102	'	'	'
Shares canceled or surrendered as payment of tax withholding	'	0	'	'	'
Repurchase of company stock (in shares)	'	-17,490	'	'	'
Repurchase of company stock	-43,170	-21	'	-43,149	'
Currency translation adjustment	-466	'	'	'	-466
Net income	6,538	'	'	6,538	'
Ending Balance at Dec. 31, 2013	-548	104	113,014	-113,087	-579
Ending Balance (in shares) at Dec. 31, 2013	'	103,898	'	'	'
Beginning Balance at Sep. 30, 2013	'	'	'	'	'
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'	'	'	'	'
Issuance of shares related to restricted stock (in shares)	'	125	'	'	'
Shares canceled or surrendered as payment of tax withholding (in shares)	'	-48	'	'	'
Currency translation adjustment	-192	'	'	'	'
Net income	3,282	'	'	'	'
Ending Balance at Dec. 31, 2013	($548)	$104	'	'	'
Ending Balance (in shares) at Dec. 31, 2013	'	103,898	'	'	'

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Cash Flows from Operating Activities:	'	'
Net income	$6,538,000	$4,373,000
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation and amortization	997,000	681,000
Stock-based compensation	1,475,000	1,051,000
Amortization of deferred financing fees	39,000	0
Amortization of debt discount	30,000	0
Impairment of inventory	0	4,176,000
Changes in operating assets and liabilities:	'	'
Decrease/(increase) in accounts receivable	2,395,000	-395,000
Decrease/(increase) in inventory	529,000	-2,375,000
Increase in prepaid expenses and deposits	-1,888,000	-3,098,000
Increase in other long-term assets	0	-1,183,000
Increase/(decrease) in accounts payable	-2,364,000	1,162,000
Increase/(decrease) in accrued expenses	-767,000	1,547,000
Increase/(decrease) in other long-term liabilities	-68,000	423,000
Net Cash Provided by Operating Activities	6,916,000	6,362,000
Cash Flows from Investing Activities:	'	'
Purchase of equipment	-659,000	-3,870,000
Net Cash Used in Investing Activities	-659,000	-3,870,000
Cash Flows from Financing Activities:	'	'
Proceeds from term loan	45,825,000	0
Payment of deferred financing fees	-1,511,000	0
Repurchase of company stock	-43,170,000	-238,000
Exercise of options and warrants	1,152,000	1,501,000
Net Cash Provided by Financing Activities	2,296,000	1,263,000
Foreign Currency Effect on Cash	-398,000	63,000
Increase in Cash and Cash Equivalents:	8,155,000	3,818,000
Cash and Cash Equivalents - beginning of period	26,299,000	24,648,000
Cash and Cash Equivalents - end of period	34,454,000	28,466,000
Non Cash Investing and Financing Activities:	'	'
Increase in property and equipment/other long-term liabilities	0	418,000
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION	'	'
Cash paid for interest expense	413,000	0
Cash paid for income taxes	$1,869,000	$5,400,000

Organization_and_Basis_of_Pres

Organization and Basis of Presentation (Notes)	6 Months Ended
	Dec. 31, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Organization and Basis of Presentation	'
	Organization and Basis of Presentation:
	The condensed consolidated financial statements included herein have been prepared by the Company’s management, without audit, pursuant to the rules and regulations of the SEC. In the opinion of the Company’s management, these interim Financial Statements include all adjustments, consisting of normal recurring adjustments, that are considered necessary for a fair presentation of its financial position as of December 31, 2013, and the results of operations for the three and six months ended December 31, 2013 and 2012 and the cash flows for the six months ended December 31, 2013 and 2012. Interim results are not necessarily indicative of results for a full year or for any future period.
	The condensed consolidated financial statements and notes included herein are presented as required by Form 10-Q, and do not contain certain information included in the Company’s audited financial statements and notes for the fiscal year ended June 30, 2013 pursuant to the rules and regulations of the SEC. For further information, refer to the financial statements and notes thereto as of and for the year ended June 30, 2013, and included in the Annual Report on Form 10-K on file with the SEC.

Summary_of_Significant_Account

Summary of Significant Accounting Policies (Notes)	6 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Summary of Significant Accounting Policies	'
	Summary of Significant Accounting Policies:
	Consolidation
	The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.
	Use of Estimates
	Management has made a number of estimates and assumptions relating to the reporting of revenues, expenses, assets and liabilities and the disclosure of contingent assets and liabilities to prepare these consolidated financial statements. Actual results could differ from those estimates.
	Translation of Foreign Currency Statements
	A portion of the Company’s business operations occurs outside the United States. The local currency of each of the Company’s subsidiaries is generally its functional currency. All assets and liabilities are translated into U.S. dollars at exchange rates existing at the balance sheet dates, revenue and expenses are translated at weighted-average exchange rates and stockholders’ equity is recorded at historical exchange rates. The resulting foreign currency translation adjustments are recorded as a separate component of stockholders’ equity in the consolidated balance sheets and transaction gains and losses are included in interest and other income (expense), net in the consolidated financial statements.
	Currency translation gains and losses on intercompany balances denominated in a foreign currency are recorded as other income (expense), net. A net foreign currency loss of $187,000 and $334,000 is recorded in other income (expense), net for the three and six months ended December 31, 2013.
	Derivative Instruments and Hedging Activities
	The Company's subsidiaries enter into transactions with each other which may not be denominated in the respective subsidiaries' functional currencies. The Company seeks to reduce its exposure to fluctuations in foreign exchange rates through the use of derivatives. The Company does not use such derivative financial instruments for trading or speculative purposes.
	To hedge risks associated with the foreign-currency-denominated intercompany transactions the Company entered into forward foreign exchange contracts which were settled in December 2013 and were not designated for hedge accounting. For the three and six months ended December 31, 2013, a realized gain of $333,000 and $184,000, related to forward contracts, is recorded in other income (expense), net. The Company did not hold any derivative instruments at December 31, 2013.
	Cash and Cash Equivalents
	The Company considers only its monetary liquid assets with original maturities of three months or less as cash and cash equivalents.
	Concentration of Credit Risk
	The Company discloses significant concentrations of credit risk regardless of the degree of such risk. Financial instruments with significant credit risk include cash and investments. At December 31, 2013, the Company had $31.1 million in cash accounts that were held primarily at one financial institution and $3.4 million in accounts at other financial institutions. As of December 31, 2013 and June 30, 2013 the Company’s cash balances exceeded federally insured limits.
	Accounts Receivable
	The Company’s accounts receivable for the periods ended December 31, 2013 and June 30, 2013 consist primarily of credit card receivables. Based on the Company’s verification process for customer credit cards and historical information available, management has determined that an allowance for doubtful accounts on credit card sales related to its customer sales as of December 31, 2013 is not necessary. No bad debt expense has been recorded for the periods ended December 31, 2013 and December 31, 2012.
	Inventory
	Inventory is stated at the lower of cost or market value. Cost is determined using the first-in, first-out method. The Company has capitalized payments to its contract product manufacturer for the acquisition of raw materials and commencement of the manufacturing, bottling and labeling of its product. As of December 31, 2013 and June 30, 2013, inventory consisted of (in thousands):
		December 31,		June 30,
		2013		2013
	Finished goods	$	6,200	$	5,273
	Raw materials	3,643		5,251
	Total inventory	$	9,843	$	10,524
	Revenue Recognition
	The Company ships the majority of its product directly to the consumer and receives substantially all payment for these sales in the form of credit card receipts. Revenue from direct product sales to customers is recognized upon passage of title and risk of loss. Estimated returns are recorded when product is shipped. The Company’s return policy is to provide a full refund for product returned within 30 days if the returned product is unopened or defective. After 30 days, the Company generally does not issue refunds to direct sales customers for returned product. The Company allows terminating distributors to return unopened, unexpired product that they have purchased within the prior twelve months, subject to certain consumption limitations, for a full refund, less a 10% restocking fee. The Company establishes the returns reserve based on historical experience. The returns reserve is evaluated on a quarterly basis. As of December 31, 2013 and June 30, 2013, the Company’s reserve balance for returns and allowances was approximately $0.8 million and $0.6 million, respectively.
	Shipping and Handling
	Shipping and handling costs associated with inbound freight and freight out to customers, including independent distributors, are included in cost of sales. Shipping and handling fees charged to all customers are included in sales.
	Research and Development Costs
	The Company expenses all costs related to research and development activities as incurred. Research and development expenses for the six months ended December 31, 2013 and 2012 were approximately $0.9 million and $1.3 million, respectively.
	Stock-Based Compensation
	The Company recognizes stock-based compensation by measuring the cost of services to be rendered based on the grant date fair value of the equity award. The Company recognizes stock-based compensation, net of any estimated forfeitures, over the period an employee is required to provide service in exchange for the award, generally referred to as the requisite service period.
	The Black-Scholes option pricing model is used to estimate the fair value of stock options. The determination of the fair value of stock options is affected by the Company's stock price and a number of assumptions, including expected volatility, expected life, risk-free interest rate and expected dividends. The Company uses historical volatility as the expected volatility assumption required in the Black-Scholes model. The Company utilizes a simplified method for estimating the expected life of the options. The Company uses this method because it believes that it provides a better estimate than the Company’s historical data as post vesting exercises have been limited. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected terms of the stock options.
	The fair value of restricted stock grants is based on the closing market price of the Company's stock on the date of grant less the Company's expected dividend yield. The fair value of performance based awards, accounted for as liabilities, to be paid in cash is remeasured at the end of each reporting period and is based on the closing market price of the Company’s stock on the last day of the reporting period. The Company recognizes compensation costs for awards with performance conditions when it concludes it is probable that the performance conditions will be achieved. The Company reassesses the probability of vesting at each balance sheet date and adjusts compensation.
	Income Taxes
	Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period that includes the effective date of the change.
	For the six months ended December 31, 2013 and 2012 the Company has recognized income tax expense of $3.4 million and $3.0 million, respectively, which is the Company’s estimated federal, state and foreign income tax liability. Realization of deferred tax assets is dependent upon future earnings in specific tax jurisdictions, the timing and amount of which are uncertain. The Company continues to evaluate the realizability of the deferred tax asset based upon achieved and estimated future results. The difference between the six months ended December 31, 2013 effective rate of 34.0% and the Federal statutory rate of 35.0% is due to state income taxes (net of federal benefit), and certain permanent differences between taxable and book income.
	Income Per Share
	Basic income per common share is computed by dividing the net income or loss by the weighted average number of common shares outstanding during the period. Diluted income per common share is computed by dividing net income by the weighted average number of common shares and potentially dilutive common share equivalents. For the three and six months ended December 31, 2013 the effects of approximately 0.6 million and 0.7 million common shares, respectively, issuable upon exercise of options granted pursuant to the Company’s 2007 and 2010 Long-Term Incentive Plans are not included in computations because their effect was anti-dilutive. For the three and six months ended December 31, 2012 the effects of approximately 0.7 million and 0.3 million common shares, respectively, issuable upon exercise of options granted pursuant to the Company’s 2007 and 2010 Long-Term Incentive Plans are not included in computations because their effect was anti-dilutive.
	The following is a reconciliation of earnings per share and the weighted-average common shares outstanding for purposes of computing basic and diluted net income per share (in thousands except per share amounts):
		Three Months Ended				Six Months Ended
		December 31,				December 31,
		2013		2012		2013		2012
	Numerator:
	Net income	$	3,282	$	209	$	6,538	$	4,373
	Denominator:
	Basic weighted-average common shares outstanding	105,770		113,449		110,218		112,158
	Effect of dilutive securities:
	Stock awards and options	2,935		4,936		3,347		5,026
	Warrants	3,687		8,746		3,798		8,862
	Diluted weighted-average common shares outstanding	112,392		127,131		117,363		126,046
	Net income per share, basic	$	0.03	$	0	$	0.06	$	0.04
	Net income per share, diluted	$	0.03	$	0	$	0.06	$	0.03
	Segment Information
	The Company operates in a single operating segment by selling products to a global network of independent distributors that operates in an integrated manner from market to market. Selling expenses are the Company’s largest expense comprised of the commissions paid to its worldwide independent distributors. The Company manages its business primarily by managing its global network of independent distributors. The Company reports revenue in two geographic regions: Americas and Asia/Pacific. Revenues by geographic area are as follows (in thousands):
		Three Months Ended				Six Months Ended
		December 31,				December 31,
		2013		2012		2013		2012
	Americas	$	34,418	$	32,112	$	68,916	$	64,419
	Asia/Pacific	17,120		21,326		33,950		41,878
	Total revenues	$	51,538	$	53,438	$	102,866	$	106,297
	Additional information as to the Company’s revenue from operations in the most significant geographical areas is set forth below (in thousands):
		Three Months Ended				Six Months Ended
December 31,				December 31,
	2013		2012		2013		2012
United States	$	33,317	$	31,789	$	66,796	$	63,854
Japan	$	14,340	$	20,468	$	28,920	$	39,999
As of December 31, 2013 long-lived assets were $6.3 million in the U.S. and $2.5 million in Japan. As of June 30, 2013 long-lived assets were $4.8 million in the U.S. and $3.0 million in Japan.
Effect of New Accounting Pronouncements
The Company has reviewed recently issued, but not yet effective, accounting pronouncements and does not believe any such pronouncements will have a material impact on its financial statements.

LongTerm_Debt_Notes

Long-Term Debt (Notes)	6 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Long-Term Debt	'
	Long-Term Debt
	On October 18, 2013 the Company entered into a Financing Agreement providing for a term loan facility in an aggregate principal amount of $47 million (the “Term Loan”) and a delayed draw term loan facility in an aggregate principal amount not to exceed $20 million (the “Delayed Draw Term Loan” and collectively with the Term Loan, the “Credit Facility”). The Delayed Draw Term Loan is available for borrowing in specified minimum amounts from time to time beginning after the effective date (as defined in the Financing Agreement) until October 18, 2014 or until the Delayed Draw Term Loan is reduced to zero, if earlier. As of December 31, 2013 the Company had not borrowed any amounts under the Delayed Draw Term Loan.
	The principal amount of the Term Loan is payable in consecutive quarterly installments beginning with the calendar quarter ending March 31, 2014 and matures on the earlier of October 18, 2018 or such date as the outstanding loans become payable in accordance with the terms of the Financing Agreement (the “Final Maturity Date”). In the event the Company borrows under the Delayed Draw Term Loan, the outstanding principal will be payable in consecutive quarterly installments beginning with the calendar quarter ending December 31, 2014 through the Final Maturity Date. Each of the loans will bear interest at a rate equal to 7.5% per annum plus the greater of (i) 1.25% or (ii) LIBOR, or at the Company’s option, a reference rate (as defined in the Financing Agreement) plus 6.5% per annum, with such interest payable monthly. For the six months ended December 31, 2013 the interest rate was 8.75%.
	The Company’s obligations under the Credit Facility are secured by a security interest in substantially all of the Company’s assets. Loans outstanding under the Credit Facility (1) must be prepaid based on certain cash flow metrics and with any net proceeds of certain permitted asset sales and (2) may be prepaid in whole or in part at any time, with any prepayments made prior to the first anniversary of the effective date subject to a prepayment premium. Any principal amount of the loans which is prepaid or repaid may not be re-borrowed.
	The Credit Facility contains customary negative covenants that, among other things, restrict the Company from undertaking specified corporate actions such as, creation of liens, incurrence of additional indebtedness, making certain investments with affiliates, changes of control, having excess foreign cash, issuance of equity, repurchasing the Company's equity securities in the public markets, and making certain restricted payments, including dividends. The Credit Facility also contains various financial covenants that require the Company to maintain a certain consolidated EBITDA, certain leverage and fixed charges ratios as well as a minimum level of liquidity. Additionally, the Credit Facility contains cross-default provisions, whereby a default pursuant to the terms and conditions of certain indebtedness will cause a default on the remaining indebtedness under the Credit Facility. At December 31, 2013, the Company was in compliance with the covenants under its long-term indebtedness.
	The Company incurred transaction costs associated with the Credit Facility totaling $2.7 million, of which $69,000 was recorded in interest expense during the quarter ended December 31, 2013. The remaining $2.6 million consists of unamortized deferred debt offering costs and debt discount included in the accompanying consolidated balance sheet and are amortized to interest expense using the interest method.
	The Company’s book value for the Credit Facility approximates the fair value. Aggregate future principal payments required in accordance with the terms of the Credit Facility are as follows (in thousands):
	Year Ending June 30,	Amount
	2014 (remaining six months ending June 30, 2014)	$	2,350
	2015	4,700
	2016	4,700
	2017	4,700
	2018	4,700
	Thereafter	25,850
		$	47,000

Stockholders_Equity_Notes

Stockholders' Equity (Notes)	6 Months Ended
	Dec. 31, 2013
Equity [Abstract]	'
Stockholders' Equity	'
	Stockholders’ Equity
	During the three and six months ended December 31, 2013 the Company issued 125,000 shares of restricted stock and 2.4 million and 4.3 million shares, respectively, of common stock upon the exercise of warrants and options. During the three and six months ended December 31, 2013 48,000 and 102,000 shares, respectively, of restricted stock were canceled or surrendered as payment of tax withholding upon vesting.
	On March 22, 2013 the Company announced a share repurchase program authorizing it to repurchase up to $5 million of shares of the Company's common stock. As part of that repurchase program, the Company entered into a pre-arranged stock repurchase plan that operated in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934. During the six months ended December 31, 2013 the Company repurchased 1.2 million shares under this repurchase authorization. As of December 31, 2013, the Company had purchased the full $5 million in shares authorized under this repurchase program.
	On November 1, 2013, the Company accepted for payment an aggregate of 16.3 million shares of its common stock at an aggregate purchase price of $40 million as a result of its modified Dutch auction tender offer (the "Tender Offer") that expired October 25, 2013. The Company incurred transaction costs of $0.3 million related to the Tender Offer. The Company entered into the Credit Facility to finance this repurchase, (see Note 3).
	The Company’s Articles of Incorporation authorize the issuance of preferred shares. However, as of December 31, 2013, none have been issued nor have any rights or preferences been assigned to the preferred shares by the Company’s Board of Directors.

Sharebased_Compensation_Notes

Share-based Compensation (Notes)	6 Months Ended
	Dec. 31, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Share-based Compensation	'
	Share-based Compensation
	Long-Term Incentive Plans
	The Company adopted and the shareholders approved the 2007 Long-Term Incentive Plan (the “2007 Plan”), effective November 21, 2006, to provide incentives to certain eligible employees, directors and consultants. A maximum of 10.0 million shares of the Company's common stock can be issued under the 2007 Plan in connection with the grant of awards. Awards to purchase common stock have been granted pursuant to the 2007 Plan and are outstanding to various employees, officers, directors, Scientific Advisory Board members and independent distributors at prices between $0.21 and $1.50 per share, with initial vesting periods of one to three years. Awards expire in accordance with the terms of each award and the shares subject to the award are added back to the 2007 Plan upon expiration of the award. The contractual term of stock options granted is generally ten years. As of December 31, 2013 there were awards outstanding, net of awards expired, for the purchase in aggregate of 2.6 million shares of the Company's common stock.
	The Company adopted and the shareholders approved the 2010 Long-Term Incentive Plan (the “2010 Plan”), effective September 27, 2010, as amended on January 10, 2012, to provide incentives to eligible employees, directors and consultants who contribute to the strategic and long-term performance objectives and growth of the Company. A maximum of 6.9 million shares of the Company’s common stock can be issued under the 2010 Plan in connection with the grant of awards. Awards to purchase common stock have been granted pursuant to the 2010 Plan and are outstanding to various employees, officers and directors. Outstanding stock options awarded under the 2010 Plan have exercise prices between $0.63 and $3.53 per share, and vest over one to four year vesting periods. Awards expire in accordance with the terms of each award and the shares subject to the award are added back to the 2010 Plan upon expiration of the award. The contractual term of stock options granted is generally ten years. As of December 31, 2013 there were awards outstanding, net of awards expired, for an aggregate of 3.5 million shares of the Company’s common stock.
	The Company adopted a Performance Incentive Plan (the “Performance Plan”), effective July 1, 2013, to provide selected employees an opportunity to earn performance-based cash bonuses whose value is based upon the Company’s stock value and to encourage such employees to provide services to the Company and to attract new individuals with outstanding qualifications. The Performance Plan seeks to achieve this purpose by providing for awards in the form of performance share units (the “Units”). No shares will be issued under the Performance Plan. Awards may be settled only with cash and will be paid subsequent to award vesting. The fair value of share-based compensation awards, that include performance shares, are accounted for as liabilities. Vesting for the Units is subject to achievement of both service-based and performance-based vesting requirements. Performance-based vesting occurs in three installments if the Company meets certain performance criteria generally set for each year of a three-year performance period. The service-based vesting criteria occurs in three annual installments which are achieved at the end of a given fiscal year only if the participant has continuously remained in service from the date of award through the end of that fiscal year. The fair value of these awards is based on the trading price of our common stock and is remeasured at each reporting period date until settlement.
	Stock-Based Compensation
	In accordance with accounting guidance for stock based compensation, payments in equity instruments for goods or services are accounted for under the fair value method. For the three and six months ended December 31, 2013, stock based compensation of $0.7 million and $1.5 million was reflected as an increase to additional paid in capital, all of which was employee related and $22,000 was reflected as an increase to other accrued expenses. For the three and six months ended December 31, 2012, stock based compensation of $0.6 million and $1.1 million, was reflected as an increase to additional paid in capital, all of which was employee related.
	For the six months ended December 31, 2013, no stock options were awarded. For the six months ended December 31, 2012, the fair value of stock option awards was estimated using the Black-Scholes option-pricing model with the following assumptions and weighted-average fair values:
		Six Months Ended
		December 31,
		2013	2012
	Risk-free interest rate	N/A	0.46% - 1.03%
	Dividend yield	N/A	—	%
	Expected life in years	N/A	3.0 - 6.0
	Expected volatility	N/A	113% - 127%

Contingencies_Notes

Contingencies (Notes)	6 Months Ended
	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Contingencies	'
	Contingencies
	The Company is occasionally involved in lawsuits and disputes arising in the normal course of business. In the opinion of management, based upon advice of counsel, the likelihood of an adverse outcome in any litigation currently pending against the Company is remote. As such, management currently believes that the ultimate outcome of these lawsuits will not have a material impact on the Company's financial position or results of operations.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Consolidation	'
	Consolidation
	The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.
Use of Estimates	'
	Use of Estimates
	Management has made a number of estimates and assumptions relating to the reporting of revenues, expenses, assets and liabilities and the disclosure of contingent assets and liabilities to prepare these consolidated financial statements. Actual results could differ from those estimates.
Translation of Foreign Currency Statements	'
	Translation of Foreign Currency Statements
	A portion of the Company’s business operations occurs outside the United States. The local currency of each of the Company’s subsidiaries is generally its functional currency. All assets and liabilities are translated into U.S. dollars at exchange rates existing at the balance sheet dates, revenue and expenses are translated at weighted-average exchange rates and stockholders’ equity is recorded at historical exchange rates. The resulting foreign currency translation adjustments are recorded as a separate component of stockholders’ equity in the consolidated balance sheets and transaction gains and losses are included in interest and other income (expense), net in the consolidated financial statements.
	Currency translation gains and losses on intercompany balances denominated in a foreign currency are recorded as other income (expense), net.
Derivative Instruments and Hedging Activities	'
	Derivative Instruments and Hedging Activities
	The Company's subsidiaries enter into transactions with each other which may not be denominated in the respective subsidiaries' functional currencies. The Company seeks to reduce its exposure to fluctuations in foreign exchange rates through the use of derivatives. The Company does not use such derivative financial instruments for trading or speculative purposes.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	The Company considers only its monetary liquid assets with original maturities of three months or less as cash and cash equivalents.
Concentration of Credit Risk	'
	Concentration of Credit Risk
	The Company discloses significant concentrations of credit risk regardless of the degree of such risk. Financial instruments with significant credit risk include cash and investments. At December 31, 2013, the Company had $31.1 million in cash accounts that were held primarily at one financial institution and $3.4 million in accounts at other financial institutions.
Accounts Receivable	'
	Accounts Receivable
	The Company’s accounts receivable for the periods ended December 31, 2013 and June 30, 2013 consist primarily of credit card receivables. Based on the Company’s verification process for customer credit cards and historical information available, management has determined that an allowance for doubtful accounts on credit card sales related to its customer sales as of December 31, 2013 is not necessary.
Inventory	'
	Inventory
	Inventory is stated at the lower of cost or market value. Cost is determined using the first-in, first-out method. The Company has capitalized payments to its contract product manufacturer for the acquisition of raw materials and commencement of the manufacturing, bottling and labeling of its product.
Revenue Recognition	'
	Revenue Recognition
	The Company ships the majority of its product directly to the consumer and receives substantially all payment for these sales in the form of credit card receipts. Revenue from direct product sales to customers is recognized upon passage of title and risk of loss. Estimated returns are recorded when product is shipped. The Company’s return policy is to provide a full refund for product returned within 30 days if the returned product is unopened or defective. After 30 days, the Company generally does not issue refunds to direct sales customers for returned product. The Company allows terminating distributors to return unopened, unexpired product that they have purchased within the prior twelve months, subject to certain consumption limitations, for a full refund, less a 10% restocking fee. The Company establishes the returns reserve based on historical experience. The returns reserve is evaluated on a quarterly basis.
Shipping and Handling	'
	Shipping and Handling
	Shipping and handling costs associated with inbound freight and freight out to customers, including independent distributors, are included in cost of sales. Shipping and handling fees charged to all customers are included in sales.
Research and Development Costs	'
	Research and Development Costs
	The Company expenses all costs related to research and development activities as incurred.
Stock-Based Compensation	'
	Stock-Based Compensation
	The Company recognizes stock-based compensation by measuring the cost of services to be rendered based on the grant date fair value of the equity award. The Company recognizes stock-based compensation, net of any estimated forfeitures, over the period an employee is required to provide service in exchange for the award, generally referred to as the requisite service period.
	The Black-Scholes option pricing model is used to estimate the fair value of stock options. The determination of the fair value of stock options is affected by the Company's stock price and a number of assumptions, including expected volatility, expected life, risk-free interest rate and expected dividends. The Company uses historical volatility as the expected volatility assumption required in the Black-Scholes model. The Company utilizes a simplified method for estimating the expected life of the options. The Company uses this method because it believes that it provides a better estimate than the Company’s historical data as post vesting exercises have been limited. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected terms of the stock options.
	The fair value of restricted stock grants is based on the closing market price of the Company's stock on the date of grant less the Company's expected dividend yield. The fair value of performance based awards, accounted for as liabilities, to be paid in cash is remeasured at the end of each reporting period and is based on the closing market price of the Company’s stock on the last day of the reporting period. The Company recognizes compensation costs for awards with performance conditions when it concludes it is probable that the performance conditions will be achieved. The Company reassesses the probability of vesting at each balance sheet date and adjusts compensation.
Income Taxes	'
	Income Taxes
	Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period that includes the effective date of the change.
Income Per Share	'
	Income Per Share
	Basic income per common share is computed by dividing the net income or loss by the weighted average number of common shares outstanding during the period. Diluted income per common share is computed by dividing net income by the weighted average number of common shares and potentially dilutive common share equivalents.
Segment Information	'
	Segment Information
	The Company operates in a single operating segment by selling products to a global network of independent distributors that operates in an integrated manner from market to market. Selling expenses are the Company’s largest expense comprised of the commissions paid to its worldwide independent distributors. The Company manages its business primarily by managing its global network of independent distributors. The Company reports revenue in two geographic regions: Americas and Asia/Pacific.
Effect of New Accounting Pronouncements	'
	Effect of New Accounting Pronouncements
	The Company has reviewed recently issued, but not yet effective, accounting pronouncements and does not believe any such pronouncements will have a material impact on its financial statements

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Components of Inventory	'
	As of December 31, 2013 and June 30, 2013, inventory consisted of (in thousands):
		December 31,		June 30,
		2013		2013
	Finished goods	$	6,200	$	5,273
	Raw materials	3,643		5,251
	Total inventory	$	9,843	$	10,524
Summary of Computation of Net Income Per Share	'
	The following is a reconciliation of earnings per share and the weighted-average common shares outstanding for purposes of computing basic and diluted net income per share (in thousands except per share amounts):
		Three Months Ended				Six Months Ended
		December 31,				December 31,
		2013		2012		2013		2012
	Numerator:
	Net income	$	3,282	$	209	$	6,538	$	4,373
	Denominator:
	Basic weighted-average common shares outstanding	105,770		113,449		110,218		112,158
	Effect of dilutive securities:
	Stock awards and options	2,935		4,936		3,347		5,026
	Warrants	3,687		8,746		3,798		8,862
	Diluted weighted-average common shares outstanding	112,392		127,131		117,363		126,046
	Net income per share, basic	$	0.03	$	0	$	0.06	$	0.04
	Net income per share, diluted	$	0.03	$	0	$	0.06	$	0.03
Revenues from Unaffiliated Customers by Geographic Regions and Significant Geographic Area	'
	Revenues by geographic area are as follows (in thousands):
		Three Months Ended				Six Months Ended
		December 31,				December 31,
		2013		2012		2013		2012
	Americas	$	34,418	$	32,112	$	68,916	$	64,419
	Asia/Pacific	17,120		21,326		33,950		41,878
	Total revenues	$	51,538	$	53,438	$	102,866	$	106,297
Additional Information as to Company's Revenue from Operations in most Significant Geographical Areas	'
	Additional information as to the Company’s revenue from operations in the most significant geographical areas is set forth below (in thousands):
		Three Months Ended				Six Months Ended
		December 31,				December 31,
		2013		2012		2013		2012
	United States	$	33,317	$	31,789	$	66,796	$	63,854
	Japan	$	14,340	$	20,468	$	28,920	$	39,999

LongTerm_Debt_Tables

Long-Term Debt (Tables)	6 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Future Principal Payments of the Credit Facility	'
	Aggregate future principal payments required in accordance with the terms of the Credit Facility are as follows (in thousands):
	Year Ending June 30,	Amount
	2014 (remaining six months ending June 30, 2014)	$	2,350
	2015	4,700
	2016	4,700
	2017	4,700
	2018	4,700
	Thereafter	25,850
		$	47,000

Sharebased_Compensation_Tables

Share-based Compensation (Tables)	6 Months Ended
	Dec. 31, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Assumptions for Fair Value Measurement of Stock Options	'
	For the six months ended December 31, 2012, the fair value of stock option awards was estimated using the Black-Scholes option-pricing model with the following assumptions and weighted-average fair values:
		Six Months Ended
		December 31,
		2013	2012
	Risk-free interest rate	N/A	0.46% - 1.03%
	Dividend yield	N/A	—	%
	Expected life in years	N/A	3.0 - 6.0
	Expected volatility	N/A	113% - 127%

Summary_of_Significant_Account3

Summary of Significant Accounting Policies - Components of Inventory (Details) (USD $)	Dec. 31, 2013	Jun. 30, 2013
In Thousands, unless otherwise specified
Inventory Disclosure [Abstract]	'	'
Finished goods	$6,200	$5,273
Raw materials	3,643	5,251
Total inventory	$9,843	$10,524

Summary_of_Significant_Account4

Summary of Significant Accounting Policies - Summary of Computation of Net Income Per Share (Details) (USD $)	3 Months Ended		6 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Numerator:	'	'	'	'
Net income	$3,282	$209	$6,538	$4,373
Denominator:	'	'	'	'
Basic weighted-average common shares outstanding	105,770	113,449	110,218	112,158
Effect of dilutive securities:	'	'	'	'
Stock awards and options	2,935	4,936	3,347	5,026
Warrants	3,687	8,746	3,798	8,862
Diluted weighted-average common shares outstanding	112,392	127,131	117,363	126,046
Net income per share, basic	$0.03	$0	$0.06	$0.04
Net income per share, diluted	$0.03	$0	$0.06	$0.03

Summary_of_Significant_Account5

Summary of Significant Accounting Policies - Revenue from Unaffiliated Customers by Geographic Regions and Significant Geographic Area (Details) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Segment Reporting Information	'	'	'	'
Total revenues	$51,538	$53,438	$102,866	$106,297
Americas	'	'	'	'
Segment Reporting Information	'	'	'	'
Total revenues	34,418	32,112	68,916	64,419
Asia Pacific	'	'	'	'
Segment Reporting Information	'	'	'	'
Total revenues	17,120	21,326	33,950	41,878
UNITED STATES	'	'	'	'
Segment Reporting Information	'	'	'	'
Total revenues	33,317	31,789	66,796	63,854
JAPAN	'	'	'	'
Segment Reporting Information	'	'	'	'
Total revenues	$14,340	$20,468	$28,920	$39,999

Summary_of_Significant_Account6

Summary of Significant Accounting Policies (Details) (USD $)	3 Months Ended		6 Months Ended
Share data in Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Jun. 30, 2013
			Segment
Summary Of Significant Accounting Policies	'	'	'	'	'
Foreign currency transaction gain (loss), realized	($187,000)	'	($334,000)	'	'
Derivative instruments, gain (loss) realized in income, net	333,000	'	184,000	'	'
Money back guarantee period	'	'	'30 days	'	'
Percent of restocking fee	10.00%	'	10.00%	'	'
Reserve for sales returns	800,000	'	800,000	'	600,000
Research and development	584,000	742,000	891,000	1,257,000	'
Income tax expenses	1,519,000	262,000	3,371,000	2,963,000	'
Effective tax rate	'	'	34.00%	'	'
Statutory tax rate	'	'	35.00%	'	'
Common shares issuable upon exercise of warrants or rights	0.6	0.7	0.7	0.3	'
Number of geographic segments	'	'	2	'	'
JAPAN	'	'	'	'	'
Summary Of Significant Accounting Policies	'	'	'	'	'
Long-lived assets	2,500,000	'	2,500,000	'	3,000,000
UNITED STATES	'	'	'	'	'
Summary Of Significant Accounting Policies	'	'	'	'	'
Long-lived assets	6,300,000	'	6,300,000	'	4,800,000
Cash Accounts Held Primarily At Financial Institution	'	'	'	'	'
Summary Of Significant Accounting Policies	'	'	'	'	'
Concentration of credit risk	'	'	31,100,000	'	'
Investment Management Account At Another Financial Institution	'	'	'	'	'
Summary Of Significant Accounting Policies	'	'	'	'	'
Concentration of credit risk	'	'	$3,400,000	'	'

LongTerm_Debt_Details

Long-Term Debt (Details) (USD $)	3 Months Ended	6 Months Ended
	Dec. 31, 2013	Dec. 31, 2013	Oct. 18, 2013	Oct. 18, 2013	Dec. 31, 2013	Dec. 31, 2013
		Secured Debt	October 2013 Term Loan	October 2013 Delayed Draw Term Loan	Greater of 1.25% or LIBOR	Reference Rate at the Company's Option
			Secured Debt	Secured Debt	Secured Debt	Secured Debt
Line of Credit Facility [Line Items]	'	'	'	'	'	'
Maximum capacity on draw	'	'	$47,000,000	$20,000,000	'	'
Interest rate per annum over the variable basis	'	'	'	'	7.50%	6.50%
Minimum rate or LIBOR added to stated interest rate	'	'	'	'	1.25%	'
Interest rate during period	'	8.75%	'	'	'	'
Transaction costs associated with the Credit Facility	2,700,000	'	'	'	'	'
Interest expenses related to Credit Facility	69,000	'	'	'	'	'
Unamortized deferred debt offering costs and debt discount	$2,600,000	'	'	'	'	'

LongTerm_Debt_Future_Principal

Long-Term Debt - Future Principal Payments (Details) (USD $)	Dec. 31, 2013
In Thousands, unless otherwise specified
Debt Disclosure [Abstract]	'
2014 (remaining six months ending June 30, 2014)	$2,350
2015	4,700
2016	4,700
2017	4,700
2018	4,700
Thereafter	25,850
Long-term debt, net of unamortized discount	$47,000

Stockholders_Equity_Details

Stockholders' Equity (Details) (USD $)	0 Months Ended	1 Months Ended	3 Months Ended	6 Months Ended		9 Months Ended
	Nov. 01, 2013	Mar. 22, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Class of Stock [Line Items]	'	'	'	'	'	'
Stock issued upon exercise of warrants (in shares)	'	'	2,400,000	4,300,000	'	'
Stock repurchased amount	'	$5,000,000	'	'	'	'
Payment to purchased the full shares authorized	40,000,000	'	'	43,170,000	238,000	5,000,000
Transaction costs related to Dutch auction tender offer	$300,000	'	'	'	'	'
Pre-Arranged Stock Repurchase Plan	'	'	'	'	'	'
Class of Stock [Line Items]	'	'	'	'	'	'
Repurchase of Company stock (in shares)	'	'	'	1,163,000	'	'
Tender Offer	'	'	'	'	'	'
Class of Stock [Line Items]	'	'	'	'	'	'
Repurchase of Company stock (in shares)	16,300,000	'	'	'	'	'
Common stock	'	'	'	'	'	'
Class of Stock [Line Items]	'	'	'	'	'	'
Issuance of shares related to restricted stock (in shares)	'	'	125,000	125,000	'	'
Shares canceled or surrendered as payment of tax withholding (in shares)	'	'	48,000	102,000	'	'
Repurchase of Company stock (in shares)	'	'	'	17,490,000	'	'

Sharebased_Compensation_Detail

Share-based Compensation (Details) (USD $)

3 Months Ended

6 Months Ended

6 Months Ended

6 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Jun. 30, 2013

Dec. 31, 2013

Dec. 31, 2013

Nov. 21, 2006

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Employee Stock Option

2007 Long-Term Incentive Plan

2007 Long-Term Incentive Plan

2007 Long-Term Incentive Plan

2007 Long-Term Incentive Plan

2010 Long-Term Incentive Plan

2010 Long-Term Incentive Plan

2010 Long-Term Incentive Plan

Service

Performance

Minimum

Maximum

Minimum

Maximum

2013 Performance Incentive Plan

2013 Performance Incentive Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Shares issued

'

'

'

'

'

'

'

10,000,000

'

'

6,900,000

'

'

'

'

Right to purchase common stock, minimum price per share

'

'

'

'

'

'

$0.21

'

'

'

$0.63

'

'

'

'

Right to purchase common stock, maximum price per share

'

'

'

'

'

'

$1.50

'

'

'

$3.53

'

'

'

'

Share based payment award, vesting period (in years)

'

'

'

'

'

'

'

'

'1 year

'3 years

'

'1 year

'4 years

'

'

Common stock shares outstanding

103,898,000

'

103,898,000

'

117,088,000

'

2,600,000

'

'

'

'

'

'

'

'

Contractual term of stock options granted (in years)

'

'

'

'

'

'

'10 years

'

'

'

'10 years

'

'

'

'

Aggregate number of shares outstanding

'

'

'

'

'

'

'

'

'

'

3,500,000

'

'

'

'

Performance based vesting occurs in three installments for each year of a three-year performance period (in percent)

'

'

'

'

'

'

'

'

'

'

'

'

'

100.00%

100.00%

Stock based compensation reflect in additional paid in capital

$700,000

$600,000

$1,500,000

$1,100,000

'

'

'

'

'

'

'

'

'

'

'

Stock-based compensation awards classified as a liability settled in cash

'

'

$22,000

'

'

'

'

'

'

'

'

'

'

'

'

Stock options awarded during period (in shares)

'

'

'

'

'

0

'

'

'

'

'

'

'

'

'

Sharebased_Compensation_Fair_V

Share-based Compensation - Fair Value Assumptions (Details) (Employee Stock Option)	6 Months Ended
	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Expected dividend rate	0.00%
Minimum expected volatility	113.00%
Maximum expected volatility	127.00%
Minimum	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Risk-free interest rate	0.46%
Expected term (in years)	'3 years
Maximum	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Risk-free interest rate	1.03%
Expected term (in years)	'6 years